Genscript Biotech (GNNSF) Revenue
22 Followers
Genscript Biotech Revenue
Genscript Biotech had a revenue of 403.25M in the quarter ending Jun 30, 2026, with -8.51%. This bring the company's revenue in the last twelve months to 844.00M, Decreased 12.04%. In the fiscal year ending Dec 31, 2025, Genscript Biotech had annual revenue of 959.53M with 61.40% growth.
- Revenue (ttm)
- 844.00M
- Revenue Growth
- 53.11%
- P/S Ratio
- 10.17
- Revenue/Employee
- $156,402
- Employees
- 6,135
- Market Cap
- $9.76B
Revenue Chart
Genscript Biotech Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 959.53M | 365.04M | 61.40% |
| Dec 31, 2024 | 594.49M | 34.01M | 6.07% |
| Dec 31, 2023 | 560.48M | -65.22M | -10.42% |
| Dec 31, 2022 | 625.70M | 135.60M | 27.67% |
| Dec 31, 2021 | 490.10M | 99.25M | 25.39% |
| Dec 31, 2020 | 390.85M | 117.49M | 42.98% |
| Dec 31, 2019 | 273.35M | 42.34M | 18.33% |
| Dec 31, 2018 | 231.02M | 78.37M | 51.34% |
| Dec 31, 2017 | 152.65M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.